Cure8 research brief
The study suggests a specific microbial metabolite, 3‑HPA, can link cold exposure to worse colitis by changing the microbiome and harming epithelial cell mitochondria and barrier function — a possible new mechanistic target for research.
Researchers (microbiome, metabolism, IBD), clinicians interested in environmental triggers and mechanisms of flares, and informed patients curious about basic‑science advances.
This paper used a DSS colitis mouse model plus metagenomics/metabolomics to link cold exposure with higher fecal 3‑HPA and worse colitis measures (weight loss, histologic injury, immune infiltration). Giving 3‑HPA directly also worsened disease in mice.
Multi-omics results suggest 3‑HPA shifts microbial composition and reduces short‑chain fatty acids and other beneficial microbial metabolites. In intestinal epithelial cells in vitro, 3‑HPA impaired oxidative phosphorylation, lowered ATP, and disrupted tight junctions under nutrient‑limited conditions.
The study is preclinical: findings are from mouse models and cell experiments and do not prove the same effects occur in people with IBD. The paper highlights a potential mechanistic link between an environmental stressor (cold), a microbial metabolite (3‑HPA), and epithelial dysfunction that could inform future biomarker or therapeutic research.
Results are from DSS mice and cultured intestinal epithelial cells; causal relevance and safety in humans are untested. The article is a basic‑science journal publication (abstract-level content provided).
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: National Natural Science Foundation of China, award 82322029; National Natural Science Foundation of China, award 32541024; award 82322029; award 32541024
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study suggests an environmental fungicide can disrupt gut microbes and reduce beneficial microbial tryptophan metabolites, promoting colitis in mice; dietary tryptophan reversed those effects in the model.
Fibrosis and stricturing are key problems in Crohn’s disease with limited therapies; this study identifies a microbiota–bile acid–GPBAR1 pathway by which a specific probiotic mix reduced inflammation and fibrosis in...
This preclinical study links cod skin–derived collagen peptides to reduced colitis severity in mice through changes in the gut microbiota and suppression of the NLRP3 inflammasome — pathways that could be relevant to...
